Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla < sup > TM < /sup > platform: a real-world two-center experience in Greece

CONCLUSION: The frequency of EGFR mutations was as expected for a Caucasian population. The Idylla EGFR test performance is comparable to reference methods and with a shorter TAT. Adding a concurrent plasma Idylla test to tissue NGS testing increases the detection rate of EGFR mutations in NSCLC.PMID:38193169 | DOI:10.1080/14737159.2024.2303320

Source: Expert Review of Molecular Diagnostics - January 9, 2024 Category: Laboratory Medicine Authors: Kleita Michaelidou Ioannis Karniadakis Varvara Pantelaion Chara Koutoulaki Eleni Boukla Konstantinos Folinas Pantelis Dimaras Maria A Papadaki Anastasios V Koutsopoulos Dimitrios Mavroudis Christine Vourlakou Konstantinos Mavridis Sofia Agelaki Source Type: research